Your browser doesn't support javascript.
loading
Critical care and ventilatory management of deceased organ donors impact lung use and recipient graft survival.
Swanson, Elizabeth A; Patel, Madhukar S; Hutchens, Michael P; Niemann, Claus U; Groat, Tahnee; Malinoski, Darren J; Sally, Mitchell B.
Afiliação
  • Swanson EA; Division of Trauma, Critical Care and Acute Care Surgery, Department of Surgery, Oregon Health & Science University, Portland, Oregon, USA.
  • Patel MS; Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
  • Hutchens MP; Operative Care Division, Section of Surgical Critical Care, VA Portland Health Care System, Portland, Oregon, USA.
  • Niemann CU; Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California, USA.
  • Groat T; Department of Surgery, University of California San Francisco, San Francisco, California, USA.
  • Malinoski DJ; Operative Care Division, Section of Surgical Critical Care, VA Portland Health Care System, Portland, Oregon, USA.
  • Sally MB; Division of Trauma, Critical Care and Acute Care Surgery, Department of Surgery, Oregon Health & Science University, Portland, Oregon, USA.
Am J Transplant ; 21(12): 4003-4011, 2021 12.
Article em En | MEDLINE | ID: mdl-34129720
Current risk-adjusted models for donor lung use and lung graft survival do not include donor critical care data. We sought to identify modifiable donor physiologic and mechanical ventilation parameters that predict donor lung use and lung graft survival. This is a prospective observational study of donors after brain death (DBDs) managed by 19 Organ Procurement Organizations from 2016 to 2019. Demographics, mechanical ventilation parameters, and critical care data were recorded at standardized time points during donor management. The lungs were transplanted from 1811 (30%) of 6052 DBDs. Achieving ≥7 critical care endpoints was a positive predictor of donor lung use. After controlling for recipient factors, donor blood pH positively predicted lung graft survival (OR 1.48 per 0.1 unit increase in pH) and the administration of dopamine during donor management negatively predicted lung graft survival (OR 0.19). Tidal volumes ≤8 ml/kg predicted body weight (OR 0.65), and higher positive end-expiratory pressures (OR 0.91 per cm H2 O) predicted decreased donor lung use without affecting lung graft survival. A randomized clinical trial is needed to inform optimal ventilator management strategies in DBDs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Obtenção de Tecidos e Órgãos / Sobrevivência de Enxerto Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Am J Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Obtenção de Tecidos e Órgãos / Sobrevivência de Enxerto Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Am J Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos